133 related articles for article (PubMed ID: 25779069)
1. [The expression and clinical significance of BATF2 in oral tongue squamous cell carcinoma].
Wen H; Tang J; Liu B; Sun C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jan; 50(1):13-7. PubMed ID: 25779069
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma.
Wen H; Chen Y; Hu Z; Mo Q; Tang J; Sun C
Oncol Rep; 2014 Jan; 31(1):169-74. PubMed ID: 24252932
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.
Ma H; Liang X; Chen Y; Pan K; Sun J; Wang H; Wang Q; Li Y; Zhao J; Li J; Chen M; Xia J
Int J Cancer; 2011 Feb; 128(4):771-7. PubMed ID: 20473897
[TBL] [Abstract][Full Text] [Related]
4. TRB3 overexpression due to endoplasmic reticulum stress inhibits AKT kinase activation of tongue squamous cell carcinoma.
Zhang J; Wen HJ; Guo ZM; Zeng MS; Li MZ; Jiang YE; He XG; Sun CZ
Oral Oncol; 2011 Oct; 47(10):934-9. PubMed ID: 21821462
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
[TBL] [Abstract][Full Text] [Related]
7. Does securin expression have significance in prognostication of oral tongue cancer? A pilot study.
Heikkinen I; Almangush A; Hagström J; Bello IO; Kauppila JH; Mäkinen LK; Haglund C; Nieminen P; Salo T; Leivo I
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3905-3911. PubMed ID: 27091335
[TBL] [Abstract][Full Text] [Related]
8. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
10. High expression of serine protease inhibitor kazal type 1 predicts poor prognosis and promotes the progression and invasion of oral tongue squamous cell carcinoma.
Wang S; Sun Y; Shao D; Pan Y; Gao X; Zhao P; Liu Q; Shang G; Shang W; Fu Z; Sun Y
Arch Oral Biol; 2024 Aug; 164():106003. PubMed ID: 38781741
[TBL] [Abstract][Full Text] [Related]
11. Bcl-xL overexpression and its association with the progress of tongue carcinoma.
Zhang K; Jiao K; Xing Z; Zhang L; Yang J; Xie X; Yang L
Int J Clin Exp Pathol; 2014; 7(11):7360-77. PubMed ID: 25550772
[TBL] [Abstract][Full Text] [Related]
12. m6A modification-mediated BATF2 suppresses metastasis and angiogenesis of tongue squamous cell carcinoma through inhibiting VEGFA.
Wen H; Tang J; Cui Y; Hou M; Zhou J
Cell Cycle; 2023 Jan; 22(1):100-116. PubMed ID: 35949109
[TBL] [Abstract][Full Text] [Related]
13. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M
Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
15. Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma.
Mäkinen LK; Atula T; Häyry V; Jouhi L; Datta N; Lehtonen S; Ahmed A; Mäkitie AA; Haglund C; Hagström J
Oral Oncol; 2015 Jan; 51(1):96-102. PubMed ID: 25264223
[TBL] [Abstract][Full Text] [Related]
16. The clinical value of lymphatic vessel density, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 expression in patients with oral tongue squamous cell carcinoma.
Yan J; Jiang Y; Ye M; Liu W; Feng L
J Cancer Res Ther; 2014 Nov; 10 Suppl():C125-30. PubMed ID: 25450269
[TBL] [Abstract][Full Text] [Related]
17. TIPE2 suppresses progression and tumorigenesis of the oral tongue squamous cell carcinoma by regulating FoxP3
Zhao LL
J Bioenerg Biomembr; 2020 Aug; 52(4):279-289. PubMed ID: 32594290
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.
Liu PF; Hu YC; Kang BH; Tseng YK; Wu PC; Liang CC; Hou YY; Fu TY; Liou HH; Hsieh IC; Ger LP; Shu CW
PLoS One; 2017; 12(7):e0180620. PubMed ID: 28700659
[TBL] [Abstract][Full Text] [Related]
19. PTK7 is a molecular marker for metastasis, TNM stage, and prognosis in oral tongue squamous cell carcinoma.
Dong Y; Chen X; Li H; Ni Y; Han W; Wang J
Pol J Pathol; 2017; 68(1):49-54. PubMed ID: 28547980
[TBL] [Abstract][Full Text] [Related]
20. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]